Probing Protein Conformation Destabilization in Sterile Liquid Formulations through the Formation of 3,4-Dihydroxyphenylalanine

Mol Pharm. 2020 Oct 5;17(10):3783-3793. doi: 10.1021/acs.molpharmaceut.0c00554. Epub 2020 Sep 24.

Abstract

This work demonstrates the use of a fluorescent probe to screen protein conformational changes in mixtures of monoclonal antibodies and determine the region of where such changes may originate through a footprinting mass spectrometry approach. The oxidative stress of mixtures of two different immunoglobulins (IgG1, IgG2, or IgG4) performed in the presence of 2,2'-azobis(2-amidinopropane dihydrochloride) results in sequence-specific tyrosine oxidation reactions depending on the time of incubation of the IgG molecules and the nature of the excipients present in the formulation. The combination of a fluorescence assay, based on the detection of 3,4-dihydroxyphenylalanine (DOPA) and mass spectrometry analyses, permits the identification of protein conformation changes. In a mixture of IgG2 and IgG4, a destabilization of IgG4 in the presence of IgG2 is observed. The destabilized region involves the Fab region of IgG4 between Tyr63 and Tyr81 and potentially multiple regions of IgG2.

Keywords: 2,2′-azobis-(2-amidinopropane dihydrochloride); 3,4-dihydroxyphenylalanine; ABS; DOPA; FRET; monoclonal antibody; tyrosine.

MeSH terms

  • Antibodies, Monoclonal / chemistry*
  • Antibodies, Monoclonal / pharmacokinetics
  • Bioluminescence Resonance Energy Transfer Techniques
  • Dihydroxyphenylalanine / analysis*
  • Dihydroxyphenylalanine / chemistry
  • Drug Combinations
  • Drug Stability*
  • Mass Spectrometry / methods
  • Oxidation-Reduction
  • Protein Conformation
  • Protein Stability*

Substances

  • Antibodies, Monoclonal
  • Drug Combinations
  • Dihydroxyphenylalanine